RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All inter
Related Questions
Are there any notable operational developments (e.g., new contracts, supplyâchain improvements, costâsaving initiatives) that could impact future profitability?
How will OMI's Q2 performance compare to its peers in the healthcare distribution sector and to prior quarters?
What are investors' expectations for OMI's Q2 2025 earnings and how might the actual results deviate from consensus estimates?
Will the conference call include any commentary on capitalâallocation plans, such as debt repayment, share repurchases, or M&A activity, and what are the implications for shareholders?
Are there any risks or headwinds highlighted by management (e.g., regulatory scrutiny, competitive pressure) that could affect OMI's longâterm growth trajectory?
What technical or shortâterm trading opportunities could arise from the earnings release timing and postârelease price action?
How might the market react to any surprises in revenue, earnings, or cashâflow metrics announced in the earnings release?
What guidance, if any, will the company provide for Q3 2025 and the fullâyear outlook, and how could that influence the stock price?
What macroeconomic factors (e.g., inflation, interestârate environment, healthcare policy changes) might affect OMI's results and market perception?
What key financial metrics (e.g., revenue growth, margin expansion, EPS) are likely to be highlighted in the release and the conference call?